Quantcast
FDA Approves New Drug That Extends Survival in the Most

FDA Approves New Drug That Extends Survival in the Most Common Type of Lung Cancer

Provided by Peter Bracke, University of California Los Angeles The U.S. Food and Drug Administration today approved a new drug to treat non-small-cell lung cancer (NSCLC), offering patients new hope in fighting this difficult disease. Lung...

Latest Alkaloids Stories

2014-12-18 08:27:14

- Patent Covers Taxane Prodrug Nanoparticle Delivery Technology - EWING, N.J., Dec. 18, 2014 /PRNewswire/ -- Celator Pharmaceuticals, Inc.

2014-12-16 16:25:51

CYRAMZA is the first treatment approved in the U.S. for use in combination with docetaxel in second-line metastatic non-small cell lung cancer INDIANAPOLIS, Dec.

2014-12-03 12:27:09

SAN DIEGO, Dec. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.

2014-11-05 16:29:43

CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy INDIANAPOLIS, Nov.

2014-10-30 08:35:51

Trial will test the potential synergy between a taxane and TTFields in the treatment of recurrent ovarian cancer ST. HELIER, Jersey, Oct.

2014-10-23 08:36:43

Four Preclinical Study Abstracts Evaluate Anatabine Across Neurological Disorders SARASOTA, Fla., Oct. 23, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc.

2014-10-14 16:28:30

SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.

2014-10-06 08:28:52

18-MC Well Tolerated by Subjects in Development Partner's Study SAN CARLOS, Calif., Oct.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.